Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma

被引:30
|
作者
Asquith, Christopher R. M. [1 ,2 ]
Naegeli, Kaleb M. [3 ]
East, Michael P. [2 ]
Laitinen, Tuomo [4 ]
Havener, Tammy M. [3 ]
Wells, Carrow I. [1 ]
Johnson, Gary L. [2 ]
Drewry, David H. [1 ]
Zuercher, William J. [1 ,5 ]
Morris, David C. [3 ]
机构
[1] Univ N Carolina, UNC Eshelman Sch Pharm, Struct Genom Consortium, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, UNC Catalyst Rare Dis, Chapel Hill, NC 27599 USA
[4] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio 70211, Finland
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
基金
加拿大创新基金会; 巴西圣保罗研究基金会;
关键词
4-ANILINOQUINOLINES; EXPRESSION; MUTATIONS;
D O I
10.1021/acs.jmedchem.9b00350
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These compounds were characterized both in vitro and using in cell target engagement assays. The most potent chordoma inhibitors were further characterized in a kinome-wide screen demonstrating narrow spectrum profiles. While we observed a direct correlation between EGFR and antiproliferative effects on chordoma, GAK inhibition appeared to have only a limited effect.
引用
收藏
页码:4772 / 4778
页数:7
相关论文
共 50 条
  • [1] The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation
    Egawa, Jun
    Arta, Reza K.
    Lemmon, Vance P.
    Munos-Barrero, Melissa
    Shi, Yan
    Igarashi, Michihiro
    Someya, Toshiyuki
    MOLECULAR BRAIN, 2022, 15 (01)
  • [2] The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation
    Jun Egawa
    Reza K. Arta
    Vance P. Lemmon
    Melissa Muños-Barrero
    Yan Shi
    Michihiro Igarashi
    Toshiyuki Someya
    Molecular Brain, 15
  • [3] Epidermal growth factor receptor (EGFR) expression in chordoma
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 437 - 437
  • [4] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) STATUS IN CHORDOMA
    Ptaszynski, Konrad
    Szumera-Cieckiewicz, Anna
    Owczarek, Joanna
    Mrozkowiak, Anna
    Pekul, Monika
    Baranska, Joanna
    Rutkowski, Piotr
    POLISH JOURNAL OF PATHOLOGY, 2009, 60 (02) : 81 - 87
  • [5] Epidermal growth factor receptor (EGFR) expression in chordoma, fish and IHC studies
    Ptaszynski, K.
    Mrozkowiak, A.
    Suszylo, K.
    Pekul, M.
    Olszewski, W.
    HISTOPATHOLOGY, 2008, 53 : 19 - 19
  • [6] Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR-tyrosine kinase inhibitor treatment response
    Park, Ha Young
    Oh, Hyung Joo
    Kim, Ki-Hyun
    Kim, Tae-Ok
    Park, Cheol-Kyu
    Shin, Hong-Jun
    Lim, Jung-Hwan
    Kwon, Yong-Soo
    Oh, In-Jae
    Kim, Yu-Il
    Lim, Sung-Chul
    Kim, Young-Chul
    Choi, Yoo-Duk
    THORACIC CANCER, 2016, 7 (06) : 639 - 647
  • [7] Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
    Jimeno, Antonio
    Hidalgo, Manuel
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1766 (02): : 217 - 229
  • [8] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Atsushi Osoegawa
    Takafumi Hashimoto
    Yohei Takumi
    Miyuki Abe
    Tomonori Yamada
    Ryoji Kobayashi
    Michiyo Miyawaki
    Hideya Takeuchi
    Tatsuro Okamoto
    Kenji Sugio
    Investigational New Drugs, 2018, 36 : 999 - 1005
  • [9] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Yamada, Tomonori
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 999 - 1005
  • [10] Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Circulating Tumor DNA During EGFR-Tyrosine Kinase Inhibitor Treatment
    Oh, In-Jae
    Cho, Hyun-Ju
    Park, Chul-Kyu
    Kim, Young-Chul
    Yun, Ju-Sik
    Song, Sang-Yun
    Na, Kook-Joo
    Yun, Mee-Sun
    Ahn, Sung-Ja
    Seon, Hyun-Ju
    Choi, Yoo-Duk
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S605 - S605